Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate β-catenin activity in colon cancer cells

Molecular Carcinogenesis

Volumn 49, Issue 4, 2010, Pages 337-352

  Egan, Jan B ^a   Thompson, Patricia A ^a,b   Vitanov, Milen V ^c   Bartik, Leonid ^d,e   Jacobs, Elizabeth T ^a,f   Haussler, Mark R ^d,e   Gerner, Eugene W ^a,f   Jurutka, Peter W ^c,d,e  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c ARIZONA STATE UNIVERSITY WEST   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e ARIZONA STATE UNIVERSITY   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

Author keywords

1,25 dihydroxyvitamin D3; Colorectal cancer; Lithocholic acid; Single nucleotide polymorphisms; Wnt signaling

Indexed keywords

APC PROTEIN; BETA CATENIN; CALCITRIOL; LITHOCHOLIC ACID; VITAMIN D RECEPTOR;

ALLELE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CELL STRAIN CACO 2; COLON CANCER; COLON POLYPOSIS; DKK 4 GENE; DNA POLYMORPHISM; DRUG PROTEIN BINDING; FOKI GENE; GENE; GENE EXPRESSION; GENE TRANSCRIPTION INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; BETA CATENIN; CACO-2 CELLS; CALCITRIOL; COLORECTAL NEOPLASMS; DETERGENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; LITHOCHOLIC ACID; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT PROTEINS;

EID: 77951661630     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20603     Document Type: Article

References (61)

1. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: The second decade. Cell 1995;83:835-839.
2. Wood RJ, Fleet JC. The genetics of osteoporosis: Vitamin D receptor polymorphisms. Annu Rev Nutr 1998;18:233-258.
3. Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000;14:401-420.
4. Fang Y, van Meurs JB, d'Alesio A, et al. Promoter and 3′-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: The Rotterdam study. Am J Hum Genet 2005;77:807-823.
5. Park K,WooM,NamJ, Kim JC. Start codon polymorphisms in the vitaminD receptor and colorectal cancer risk. Cancer Lett 2006;237:199-206. (Pubitemid 43792522)
6. Peters U, McGlynn KA, Chatterjee N, et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2001;10:1267-1274. (Pubitemid 34027758)
7. Slattery ML, Murtaugh M, Caan B, Ma KN, Wolff R, Samowitz W. Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control 2004;15:863-872. (Pubitemid 39663862)
8. Wong HL, Seow A, Arakawa K, Lee HP, Yu MC, Ingles SA. Vitamin D receptor start codon polymorphism and colorectal cancer risk: Effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis 2003;24:1091-1095. (Pubitemid 36827261)
9. Holt PR, Arber N, Halmos B, et al. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev 2002;11:113-119.
10. Whitfield GK, Jurutka PW, Haussler CA, et al. Nuclear vitamin D receptor: Structure-function, molecular control of gene transcription, and novel bioactions. In: Feldman D, Pike JW, Glorieux, FH, editors. Vitamin D, Vol.1, 2nd edition. London: Elsevier Academic Press; 2005. pp 219-261.
11. Zhao X, Feldman D. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology 1993;132:1808-1814. (Pubitemid 23110559)
12. Halline AG, Davidson NO, Skarosi SF, et al. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells. Endocrinology 1994;134:1710-1717. (Pubitemid 24110727)
13. Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13:325-349.
14. Hulla W, Kallay E, Krugluger W, Peterlik M, Cross HS. Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: Relation to c-myc-oncogene and vitamin-D-receptor expression. Int J Cancer 1995;62:711-716.
15. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitaminDand folate: Molecular mechanisms. Nat Rev Cancer 2003;3:601-614. (Pubitemid 37328832)
16. Scaglione-Sewell BA, Bissonnette M, Skarosi S, Abraham C, Brasitus TA.A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: Roles of cyclin E, p21Waf1, and p27Kip1. Endocrinology 2000;141:3931-3939.
17. Shabahang M, Buras RR, Davoodi F, et al. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Res 1994;54:4057-4064. (Pubitemid 24980073)
18. van de Wetering M, Sancho E, Verweij C, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002;111:241-250.
19. Ylikomi T, Laaksi I, Lou YR, et al. Antiproliferative action of vitamin D. Vitam Horm 2002;64:357-406.
20. Hamada K, Umemoto A, Kajikawa A, Seraj MJ, Monden Y. In vitro formation of DNA adducts with bile acids. Carcinogenesis 1994;15:1911-1915.
21. Makishima M, Lu TT, Xie W, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002;296:1313-1316. (Pubitemid 34522785)
22. Nagengast FM, Grubben MJ, van Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 1995;31A: 1067-1070.
23. Reddy BS, Watanabe K, Weisburger JH, Wynder EL. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res 1977;37:3238-3242. (Pubitemid 8169906)
24. Fodde R, Smits R, Clevers H, APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001;1:55-67. (Pubitemid 33741881)
25. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997;275:1784-1787. (Pubitemid 27136714)
26. Lee E, Salic A, Kruger R, Heinrich R, Kirschner MW. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol 2003;1:E10.
27. Palmer HG, Gonzalez-Sancho JM, Espada J, et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of betacatenin signaling. J Cell Biol 2001;154:369-387.
28. Fukase K, Ohtsuka H, Onogawa T, et al. Bile acids repress Ecadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma. Cancer Sci 2008;99:1785-1792.
29. Palmer HG, Larriba MJ, Garcia JM, et al. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 2004;10:917-919.
30. Larriba MJ, Valle N, Palmer HG, et al. The inhibition of Wnt/ beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells. Endocr Relat Cancer 2007;14:141-151.
31. Jurutka PW, Thompson PD, Eichhorst KR, et al. Cell-specific crosstalk between the vitamin D receptor and beta-catenin signal transduction pathways in 1,25(OH)2D3 target tissues. J Bone Miner Res 2004;19:S101.
32. Shah S, Islam MN, Dakshanamurthy S, et al. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell 2006;21:799-809.
33. Jurutka PW, Hsieh JC, Remus LS, et al. Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro. J Biol Chem 1997;272:14592-14599.
34. Jimenez-Lara AM, Aranda A. Lysine 246 of the vitamin D receptor is crucial for ligand-dependent interaction with coactivators and transcriptional activity. J Biol Chem 1999;274:13503-13510. (Pubitemid 129518566)
35. Jurutka PW, Lamb TL, Dominguez CE, et al. Molecular analysis of helix-1 and helix-3 in the human vitamin D receptor reveals functional subdomains mediating hormone binding, protein stabilization, heterodimerization and interaction with coactivators. J Bone Miner Res 2001;16:S229.
36. Jurutka PW, Thompson PD, Whitfield GK, et al. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4. J Cell Biochem 2005;94:917-943.
37. Bazzi H, Fantauzzo KA, Richardson GD, Jahoda CA, Christiano AM. The Wnt inhibitor, Dickkopf 4, is induced by canonical Wnt signaling during ectodermal appendage morphogenesis. Dev Biol 2007;305:498-507. (Pubitemid 46686618)
38. Morin PJ, Sparks AB, Korinek V, et al. Activation of betacatenin-Tcf signaling in colon cancer by mutations in betacatenin or APC. Science 1997;275:1787-1790.
39. Abbas S, Nieters A, Linseisen J, et al. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 2008;10:R31.
40. Karami S, Brennan P, Hung RJ, et al. Vitamin D receptor polymorphisms and renal cancer risk in Central and Eastern Europe. J Toxicol Environ Health A 2008;71:367-372. (Pubitemid 351206458)
41. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence. Int J Cancer 2008;123:586-593.
42. Clendenen TV, Arslan AA, Koenig KL, et al. Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 2008;260:209-215.
43. Slattery ML, Wolff RK, Herrick JS, Caan BJ, Potter JD. IL6 genotypes and colon and rectal cancer. Cancer Causes Control 2007;18:1095-1105.
44. Lointier P, Wargovich MJ, Saez S, Levin B, Wildrick DM, Boman BM. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro. Anticancer Res 1987;7:817-821.
45. Pendas-Franco N, Garcia JM, Pena C, et al. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Oncogene 2008;27:4467-4477.
46. Xi Y, Formentini A, Nakajima G, Kornmann M, Ju J. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer. Oncol Rep 2008;19:257-262.
47. Aguilera O, Fraga MF, Ballestar E, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 2006;25:4116-4121.
48. Gonzalez-Sancho JM, Aguilera O, Garcia JM, et al. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 2005;24:1098-1103.
49. McKenna NJ, O'Malley BW. Minireview: Nuclear receptor coactivators-An update. Endocrinology 2002;143:2461-2465.
50. D'Errico I, Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: An intriguing link. Cell Mol Life Sci 2008;65:1523-1543.
51. Lin R, White JH. The pleiotropic actions of vitamin D. Bioessays 2003;26:21-28.
52. Rochel N, Moras D. Ligand binding domain of vitamin D receptors. Curr Top Med Chem 2006;6:1229-1241.
53. Shah S, Hecht A, Pestell R, Byers SW. Trans-repression of beta-catenin activity by nuclear receptors. J Biol Chem 2003;278:48137-48145.
54. Song LN, Gelmann EP. Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor. J Biol Chem 2005;280:37853-37867.
55. Ochs-Balcom HM, Cicek MS, Thompson CL, et al. Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis 2008. 29:1788-1793.
56. Ingles SA, Wang J, Coetzee GA, Lee ER, Frankl HD, Haile RW. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control 2001;12:607-614.
57. Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: Results of a randomized trial. J Natl Cancer Inst 2003;95:1765-1771.
58. Li C, Li Y, Gao LB, et al. Vitamin D receptor gene polymorphisms and the risk of colorectal cancer in a Chinese population. Dig Dis Sci 2008. 54:634-639.
59. Slattery ML, Yakumo K, Hoffman M, Neuhausen S. Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control 2001;12:359-364.
60. Murtaugh MA, Sweeney C, Ma KN, et al. Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer 2006;55:35-43. (Pubitemid 44477043)
61. Shah S, Pishvaian MJ, Easwaran V, Brown PH, Byers SW. The role of cadherin, beta-catenin, and AP-1 in retinoidregulated carcinoma cell differentiation and proliferation. J Biol Chem 2002;277:25313-25322. (Pubitemid 34951841)